Skip to main content
. 2022 Jul 20:jfac058. doi: 10.1093/jalm/jfac058

Table 3.

Published sensitivity and specificity of RSV tests reviewed under CLIA guidance only.

Test Manufacturer Technology Analytical time, min Sample type Age of intended patient population, years Sensitivity range,a % (95% CI) Specificity range,b % (95% CI) Studies, n References
Waived
 BD Veritor System RSV Becton, Dickinson and Company Antigen 10 Nasopharyngeal swab <6 years 67.5 (56.1–77.6) to 97.6 (NRc) 96.8 (91.1–99.3) to 100 (97.0–100) 7 (25–31)
 Alere Binax NOW RSV Abbott Antigen 15 Nasopharyngeal swab and nasopharyngeal aspirate/wash <5 years 41.2 (NR) to 90 (NR) 93.2 (92.8–93.6) to 100.0 (97–100) 13 (32–44)
 cobas Liat Influenza A/B & RSV Assay Roche Diagnostics Molecular 20 Nasopharyngeal swab Not specified 94.2 (87.9–97.9) to 100.0 (96.07–100.0) 94.29 (86.01–98.42) to 100 (97.7–100) 7 (15, 45–50)
 ID NOW RSVd Abbott Molecular 13 Nasopharyngeal swab <18 years and ≥60 years 93 (89–96) to 100 (93–100) 96 (93–98) to 98.0 (95.8–99.1) 4 (15, 51–53)
 QuickVue RSV Quidel Antigen 15 Nasopharyngeal swab and nasopharyngeal aspirate and/or nasal wash ≤18 years 25.7 (NR) to 90.1 (86.8–93.4) 98.5 (NR) to 99.5 (92–99) 4 (30, 54–56)
 Sofia RSV FIAe Quidel Antigen 15 Nasopharyngeal swab and nasopharyngeal aspirate/wash <19 years 74.8 (68.0–80.9) to 100 (82–100) 86.8 (85.7–87.4) to 100 (95.2–100) 8 (29, 30, 33, 41, 43, 57–59)
 Xpert Xpress Flu/RSV Cepheid Molecular 30 Nasopharyngeal swab and/or nasal swab Not specified 66.7 (24.1–94.0) to 98.1 (88.8–99.9) 98.1 (96.6–99.0) to 100 (99.7–100) 5 (45, 60–63)
Moderate complexity
 3M Rapid Detection RSV Test 3M Health Care Antigen 15 Nasopharyngeal swab and nasopharyngeal aspirate and/or nasal wash ≤21 years 60.0 (38.5–81.5) to 87.3 (83.8–90.1) 95.6 (93.8–96.9) to 99.6 (98.7–100) 2 (64, 65)
 Aries Flu A/B & RSV Assay Luminex Corporation Molecular 120 Nasopharyngeal swab Not specified 88.6 (58.3–97.6) to 97.1 (94.4–98.7) 98.4 (97.7–98.9) to 100.0 (98.8–100) 4 (44, 45, 47, 66)
 BioFire FilmArray Respiratory 2.1 Panel bioMérieux Molecular 45 Nasopharyngeal swab Not specified 62.5 (24.5–91.5) to 99.4 (96.9–99.9) 98.3 (97.5–98.9) to 100 (97.2–100) 4 (45, 67–69)
 Directigen EZ RSV Becton, Dickinson and Company Antigen 15 Not specified <20 years 59 (NR) to 90 (NR) 89.5 (NR) to 99.5 (97.0–100) 6 (30, 32, 42, 70–72)
 ePlex Respiratory Pathogen Panel GenMark Diagnostics Molecular 120 Nasopharyngeal swab Not specified 89.6 (80.0–94.8) to 100 (92.6–100) 98.9 (94.2–99.8) to 100 (99.8–100) 2 (73, 74)
High complexity
 Panther Fusion Flu A/B/RSV Assay Hologic, Inc. Molecular Not reported Nasopharyngeal swab Not specified 88.4 (81.1–93.1) to 100 (NR) 98.7 (97.0–99.6) to 100 (99.7–100) 6 (45, 47, 74–77)
 Simplexa Flu A/B & RSV Diasorin Molecular Molecular 60 Nasopharyngeal swab Not specified 73.3 (44.8–91.0) to 87.0 (74.5–94.2) 99.4 (96.3–99.9) to 100 (98.9–100) 3 (45, 47, 78)
a

Sensitivity and specificity ranges are not reported for RSV tests with <3 supporting subrecords.

b

Specificity ranges are not reported for RSV tests with <3 supporting subrecords.

c

Not reported.

d

The ID NOW RSV was formerly known as the Alere i RSV.

e

Fluorescence immunoassay.